highperformr logo

AM-Pharma's Overview

Total employees27
HeadquartersBunnik
Founded2002

AM-Pharma is a Dutch clinical-stage biopharmaceutical company focused on the development of ilofotase alfa, a proprietary recombinant human Alkaline Phosphatase (AP) therapeutic. This innovative enzyme-based treatment is being investigated for severe inflammatory diseases with high unmet medical needs, primarily Sepsis-associated Acute Kidney Injury (SA-AKI). AM-Pharma is also exploring its potential in Ulcerative Colitis. The company aims to significantly improve patient outcomes in critical care settings through its novel therapeutic approach.

Where is AM-Pharma's Headquarters?

HQ Function

The headquarters serves as the primary center for AM-Pharma's corporate management, research and development strategy, clinical trial oversight, and operational activities.

Notable Features:

Situated in a region known for its concentration of biotech companies and research institutions, likely near the Utrecht Science Park. The facility is equipped for advanced biopharmaceutical research and corporate operations.

Work Culture:

AM-Pharma fosters a science-driven, innovative, and collaborative work environment. Employees are typically focused on a mission to address critical unmet medical needs, emphasizing teamwork, expertise, and a commitment to rigorous scientific standards.

HQ Significance:

The Dutch headquarters is central to AM-Pharma's global strategy, coordinating international clinical trials, R&D collaborations, and strategic partnerships. Its location provides access to skilled talent and a supportive infrastructure for life sciences.

Values Reflected in HQ: The headquarters likely reflects AM-Pharma's core values of scientific excellence, innovation, patient-centricity, and integrity in research and business practices.

Location:

AM-Pharma operates with a global focus, particularly in its clinical development programs. The company conducts multinational clinical trials for ilofotase alfa, involving sites across North America, Europe, and other regions. While its main R&D and corporate functions are in the Netherlands and the US, its operational reach for patient recruitment, trial management, and regulatory engagement is international, collaborating with various Contract Research Organizations (CROs) and clinical centers worldwide.

Street Address:

Rumpsterweg 6

City:

Bunnik

State/Province:

Utrecht

Country:

Netherlands

AM-Pharma's Global Presence

Princeton, New Jersey, USA

Address: 101 Carnegie Center, Suite 105, Princeton, NJ 08540

To facilitate engagement with the U.S. Food and Drug Administration (FDA), manage clinical trial sites, connect with U.S.-based investigators and key opinion leaders, and support business development activities in the North American market.

Buying Intent Signals for AM-Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AM-Pharma

As of April 2025, AM-Pharma' leadership includes:

Erik van den Berg - Chief Executive Officer
Maarten Kraan, MD, PhD - Chief Medical Officer
Lars Boesgaard, MSc - Chief Financial Officer
Mark Vanderkelen, PhD - Chief Development Officer
Martijn van de Leur - Vice President Manufacturing and Supply Chain

Investors of AM-Pharma

AM-Pharma has been backed by several prominent investors over the years, including:

EQT Life Sciences (formerly LSP)
Forbion
Andera Partners
Ysios Capital
Kurma Partners
Eurazeo (formerly IDInvest Partners)
Pfizer Ventures
Cowen Healthcare Investments
European Innovation Council (EIC) Fund

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

AM-Pharma has maintained a stable core executive team over the past 12 months (mid-2023 to mid-2024), with no major publicly announced hires or departures at the C-suite level. The existing leadership continues to guide the company through its critical late-stage clinical trials and towards potential commercialization.

Technology (Tech Stack) used by AM-Pharma

Discover the tools AM-Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AM-Pharma Email Formats and Examples

AM-Pharma's email addresses typically follow common corporate patterns using the company domain '@am-pharma.com'. The most probable formats involve combinations of employee first and last names.

[firstinitial][lastname]@am-pharma.com

Format

evandenberg@am-pharma.com

Example

75%

Success rate

News and media

am-pharma.comMay 2, 2024

AM-Pharma Announces Last Patient Enrolled in Pivotal REVIVAL Phase III Trial of Ilofotase Alfa in Sepsis-associated Acute Kidney Injury

AM-Pharma confirmed the completion of patient enrollment for its REVIVAL Phase III clinical trial. This pivotal study evaluates the efficacy and safety of ilofotase alfa in treating patients with Sepsis-associated Acute Kidney Injury (SA-AKI). The company anticipates reporting topline results in the second half of 2024....more

am-pharma.comJanuary 10, 2024

AM-Pharma Upsizes Series F Financing to €47 Million (US$ 51 Million) with an Additional €25 Million Investment from the European Innovation Council (EIC) Fund

AM-Pharma announced an upsized Series F financing round, reaching a total of €47 million (approximately US$ 51 million). This included an additional €25 million investment from the European Innovation Council (EIC) Fund, aimed at supporting the late-stage clinical development of ilofotase alfa and pre-commercialization activities....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AM-Pharma, are just a search away.